Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695602 · ClinicalTrials.gov registry record · NA
Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02695602 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants.
The verdict
NCT02695602, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a prospective, patient blinded, randomized, clinical trial enrolling patients with symptoms and signs of nasal obstruction related to enlarged inferior turbinates. The purpose of this study is to compare two different surgical methods, both of which are already in common use, for the treatment of nasal obstruction in patients with inferior turbinate hypertrophy.
Interventions
- PROCEDURE Microdebrider-Assisted Inferior Turbinoplasty (MAIT)
- PROCEDURE Submucous Resection with non powered instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-05-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02695602
The ClinicalTrials.gov registry entry for NCT02695602 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microdebrider-Assisted Inferior Turbinoplasty (MAIT) is the first listed.
NCT02695602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02695602 about?
NCT02695602 is a clinical study titled "Trial Comparing Microdebrider-Assisted Inferior Turbinoplasty (MAIT) vs Submucous Resection (SMR)". This is a prospective, patient blinded, randomized, clinical trial enrolling patients with symptoms and signs of nasal obstruction related to enlarged inferior turbinates. The purpose of this study is to compare two different surgical methods, both of which are already in common use, for the treatme...
What is the current status of trial NCT02695602?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-02. Estimated completion is 2017-05-09.
What interventions are being tested in trial NCT02695602?
The interventions under investigation include: Microdebrider-Assisted Inferior Turbinoplasty (MAIT) (PROCEDURE), Submucous Resection with non powered instrument (PROCEDURE).
Who is sponsoring clinical trial NCT02695602?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.